January 9th Capital Market News Interpretation

1.UBS executive deems current stock market undervalued, with MSCI China Index PE at 8x, anticipating 15% upside this year. Evaluation: Positive economic outlook, bottom expectations shared by many institutions, awaiting a breakthrough point.

2.Surge in current US COVID-19 infections, second only to early 2022 peak. Hospitalizations and deaths rising. JN.1 variant now globally predominant. Evaluation: Market immune to virus-related themes; innovative drugs, traditional Chinese medicine show good gains.

3.Apple officially announces launch schedule for mixed reality headset Apple Vision Pro, available in all US Apple Stores from February 2nd, with pre-orders starting January 19th. Evaluation: Consumer VR market declined in 2023; uncertain if Apple can reverse trend. Hype already present in related themes.

4.Lithium carbonate for batteries drops to 99,000 CNY, breaking the 100,000 CNY mark. Evaluation: Lithium carbonate supply remains ample; improvement expected next year, but not substantial. Stock prices already declined; moderate medium to long-term risk.

5.Ministry of Industry and Information Technology issues guidelines for national automotive chip standard system construction. Evaluation: Chip shortage since 2021; industry expansion led to oversupply. Listed companies need a shift in strategy for stock price revival.

6.Companies like SanDee, Hisense, Veeco, Huaxia Eye, Nanshan Aluminum, Tencent, AIA, Xiaomi announce share buybacks. Meihua Bio, Xiantan, Huayi, Weixing New Material, Capital Online have important shareholders or executives increasing their stakes. Evaluation: Buybacks or executive increases signal confidence in company prospects, reflecting undervalued stock prices.

7.Blinken warns Yemen's Houthi militants attacking Red Sea vessels will face consequences. European Line options main contract drops 20%, other contracts EC2404, EC2406, EC2408, EC2410, EC2412 all hit limit down. Evaluation: European Line futures experience both bull and bear trends; caution for retail investors due to susceptibility to large fund manipulation.